Willkie represents Insight in its agreement to acquire a majority stake in leading channel data management company Zyme in a transaction valued at over $100 million.
Willkie client Insight Venture Partners has agreed to acquire a majority stake in Zyme, the market leader in the rapidly growing discipline of channel data management (CDM), in a transaction valued at over $100 million. The transaction is expected to enable Zyme to build a new solution category around its CDM technology that enables customers across the world to leverage data and analytics to optimize channel marketing, channel sales, channel inventory and partner performance.
Based in Redwood Shores, CA, Zyme provides the leading channel data management cloud platform, delivering critical downstream visibility for global companies that leverage distributors, resellers, retailers and e-tailers to sell their products. With a channel directory of more than 1.5 million partners, Zyme processes more than one billion transactions annually across more than 150 countries.
Insight Venture Partners is a leading global venture capital and private equity firm investing in high-growth software and internet-enabled companies that are driving transformative change in their industries.
The Willkie deal team was led by partners Gordon Caplan (Picture) and Morgan Elwyn and included associates Sarah Wong and Kurt Lyn.
Law Firms: Willkie Farr & Gallagher;
Clients: Insight Venture Partners;